Clinical trials for Acute leukemia
61 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 1 / Phase 2
Acute leukemia
#NCT04988555
#2022-502741-10-00
Phase 2, Bras G, H et K
Acute myeloid leukemia (AML)
None
Treated / Controled
> 60 ml/min
50-60 ml/min
MLL fusions
NPM1
1
2
3 or more
Systemic Treatment-Naive
8 recruiting sites
Sumitomo Pharma America, Inc.
Phase 1 / Phase 2
Acute leukemia
#NCT04988555
Phase 2, bras J
MLL fusions
1
2
3 or more
Systemic Treatment-Naive
8 recruiting sites
Sumitomo Pharma America, Inc.
Phase 1 / Phase 2
Acute leukemia
#NCT04988555
#2022-502741-10-00
Phase 2 - Bras I
Acute lymphoblastic leukemia (ALL)
None
> 60 ml/min
50-60 ml/min
KMT2A
1
2
3 or more
8 recruiting sites
Sumitomo Pharma America, Inc.
Phase 1 / Phase 2
Acute leukemia
#NCT05580861
#2024-513084-38-00
Acute myeloid leukemia (AML)
None
> 60 ml/min
50-60 ml/min
None
Systemic Treatment-Naive
FLT3-ITD
4 recruiting sites
Assistance Publique - Hôpitaux de Paris
Phase 1 / Phase 2
Acute leukemia
#NCT04065399
#2020-004104-34
Phase 2, Cohorte 2B
Acute myeloid leukemia (AML)
None
Treated / Controled
KMT2A
1
2
3 or more
Systemic Treatment-Naive
3 recruiting sites
Syndax Pharmaceuticals
Phase 1 / Phase 2
Acute leukemia
#NCT04065399
#2020-004104-34
Phase 2, Cohorte 2D
None
Treated / Controled
Other mutation
KMT2A
NPM1
1
2
3 or more
Systemic Treatment-Naive
3 recruiting sites
Syndax Pharmaceuticals
Phase 1 / Phase 2
Acute leukemia
#NCT04065399
#2020-004104-34
Phase 2, Cohorte 2C
Acute myeloid leukemia (AML)
None
Treated / Controled
NPM1
1
2
3 or more
Systemic Treatment-Naive
3 recruiting sites
Syndax Pharmaceuticals
Phase 1 / Phase 2
Acute leukemia
#NCT05768035
Acute lymphoblastic leukemia (ALL)
Acute myeloid leukemia (AML)
1
2
3 or more
Systemic Treatment-Naive
Allogeneic stem cell transplant
4 recruiting sites
Smart Immune SAS
Phase 1 / Phase 2
Acute leukemia
#NCT04065399
#2020-004104-34
Phase 2, Cohorte 2A
Acute lymphoblastic leukemia (ALL)
Other acute leukemia
None
Treated / Controled
KMT2A
1
2
3 or more
Systemic Treatment-Naive
3 recruiting sites
Syndax Pharmaceuticals
Phase 1 / Phase 2
Acute leukemia
#NCT04150497
Acute lymphoblastic leukemia (ALL)
B-cell (B-ALL)
2
3 or more
Systemic Treatment-Naive
4 recruiting sites
Cellectis SA